Author: Christina Wessels (Page 10 of 10)

Technology Highlight: FraudScope

Healthcare fraud in the United States costs an estimated $68 billion annually and contributes to rising healthcare costs. Common abuse of the system includes upcoding and unbundling of services, billing for services never rendered and using stolen healthcare data to file fraudulent claims.

In response to this problem, two researchers from Georgia Institute of Technology’s cybersecurity department, Dr. Musheer Ahmed and Dr. Mustaque Ahamad, developed an AI-based platform called FraudScope. The platform uses a proactive technology to automatically identify fraud schemes, including new and emerging ones. In addition to this, FraudScope stands apart as its sophisticated detection technology can be used to identify suspicious activity before claims are paid which helps maximize savings.

The FraudScope team received an award from the Coulter Translational Program during our 2016-2017 funding cycle. The funding and operational guidance provided by the Coulter Team aided in getting them start-up ready in six months, effectively reducing their development timeline by half. Dr. Ahmed noted that, “The interest, energy and focus of key skill sets around our project allowed us to move forward very quickly in a 6 month interval to potential industry partners.”

Fraudscope was founded in 2017 and in that same year successfully raised over $1.6 million in venture capital investments to assist with scaling customer acquisition and expanding product development. FraudScope currently has engagements at several large commercial health plans and has proven successful in identifying fraud schemes associated with health insurance claims.

To learn more about the FraudScope technology, visit fraud-scope.com.

Coulter Translational Program Announces Awards for Innovative Research

Six innovative biomedical research projects awarded

The Coulter Translational Program, in partnership with the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, awarded $765,000 to six biomedical research projects. These awards help bring innovations in patient care into the marketplace.

The Coulter program fund provides annual awards to Emory University and Georgia Institute of Technology research teams who create products with commercial potential that address an unmet clinical need. Funding and project management provided by the Coulter program team is used to bridge the gap in development between early stage university research and its commercialization.

Out of 54 applications in this year’s funding cycle, the below innovative projects were selected by a committee comprised of venture capitalists, industry, entrepreneurs, doctors, biomedical engineers and technology transfer experts from both universities.

  1. Antiviral Peptide: a broad-spectrum antiviral drug used for the treatment of the Influenza virus. The therapeutic discovery platform has identified therapeutic peptides with broad-spectrum antiviral activity. Principal Investigator: Joshy Jacobs, Emory University
  2. Neurodegenerative Disease Diagnostic: a mass spectrometry-based immunoassay that can detect and track biomarkers to determine progression of neurodegenerative disease earlier and more reliably that clinical manifestation of symptoms. Principal Investigators: Allan Levey, Emory University; Duc Duong, Emory University; and Nick Seyfried, Emory University
  3. Nanoparticle Screening for Gene Therapies: a high throughput DNA barcoding platform that identifies lipid nanoparticles that can deliver gene therapies to targeted tissues and organs with high specificity. Principal Investigator: James Dahlman, Georgia Tech
  4. Steerable Guidewire: a robotically steerable guidewire tip to enable greater maneuverability and navigation in vascular spaces. Principal Investigators: Jaydev Desai, Georgia Tech and Zach Bercu, Emory University
  5. TUMAAS Breast Pump: a wearable, portable breast pump that can draw milk with minimal noise. Principal Investigator: Andrea Joyner, Emory University
  6. Wheelchair In-seat Activity Tracker (WiSAT)*: an in-seat activity tracker to encourage weight shifts and reduce pressure ulcer formation. Principal Investigators: Sharon Sonenblum, Georgia Tech, and Stephen Sprigle, Georgia Tech *Support for this project is in partnership with the Rick Hansen Institute.

“There is a rich pipeline of commercializable patient-impacting technologies at Georgia Tech and Emory University. This year’s applicant pool was exceedingly competitive” says Shawna Khouri, managing director of the Coulter Translational Program. “The projects selected to be a part of this cohort have a strong potential for commercialization and we’re eager to work with our PIs to grow these opportunities and advance them aggressively toward the market.”

Page 10 of 10

Powered by WordPress & Theme by Anders Norén